TATVA — Tatva Chintan Pharma Chem Share Price
Last trade - 00:00- IN₹16.84bn
- IN₹16.84bn
- IN₹3.94bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 46.71 | ||
| PEG Ratio (f) | 0.66 | ||
| EPS Growth (f) | 241.38% | ||
| Dividend Yield (f) | 0.25% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.3 | ||
| Price to Tang. Book | 2.31 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.55 | ||
| EV to EBITDA | 41.52 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.93% | ||
| Return on Equity | 1.95% | ||
| Operating Margin | 3.82% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 2,632.39 | 3,003.59 | 4,336.47 | 4,236.12 | 3,935.04 | 3,816.25 | 5,099.5 | 13.79% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +89.26 | +38.29 | +89.12 | -51.65 | -38.32 | -65.81 | +241.38 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of verity of chemicals include structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts and solutions (ESS) for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). The Company operates in single segment, namely Specialty chemical business. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. The Company is focused on serving various customers across various industries, including the automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care and flavors and fragrances industries. The Company’s subsidiaries are Tatva Chintan Europe B.V. and Tatva Chintan USA Inc.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 12th, 1996
- Public Since
- July 29th, 2021
- No. of Shareholders
- 74,898
- No. of Employees
- 689
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 23,392,055
- Address
- Plot No. 353 G.I.D.C, Makarpura, VADODARA, 390010
- Web
- https://www.tatvachintan.com/
- Phone
- +91 7574848533
- Contact
- Ishwar Nayi
- Auditors
- NDJ & Co
Similar to TATVA
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Advanced Enzyme Technologies
National Stock Exchange of India
FAQ
As of Today at 23:35 UTC, shares in Tatva Chintan Pharma Chem are trading at IN₹725.50. This share price information is delayed by 15 minutes.
Shares in Tatva Chintan Pharma Chem last closed at IN₹725.50 and the price had moved by -41.71% over the past 365 days. In terms of relative price strength the Tatva Chintan Pharma Chem share price has underperformed the S&P BSE 100 Index by -45.09% over the past year.
The overall consensus recommendation for Tatva Chintan Pharma Chem is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Tatva Chintan Pharma Chem dividend yield is 0.28% based on the trailing twelve month period.
Last year, Tatva Chintan Pharma Chem paid a total dividend of IN₹2.00, and it currently has a trailing dividend yield of 0.28%. We do not have any data on when Tatva Chintan Pharma Chem is to next pay dividends.
We do not have data on when Tatva Chintan Pharma Chem is to next pay dividends. The historic dividend yield on Tatva Chintan Pharma Chem shares is currently 0.28%.
To buy shares in Tatva Chintan Pharma Chem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹725.50, shares in Tatva Chintan Pharma Chem had a market capitalisation of IN₹16.84bn.
Here are the trading details for Tatva Chintan Pharma Chem:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: TATVA
Based on an overall assessment of its quality, value and momentum Tatva Chintan Pharma Chem is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Tatva Chintan Pharma Chem is IN₹1,070.61. That is 47.57% above the last closing price of IN₹725.50.
Analysts covering Tatva Chintan Pharma Chem currently have a consensus Earnings Per Share (EPS) forecast of IN₹4.55 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tatva Chintan Pharma Chem. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -19.03%.
As of the last closing price of IN₹725.50, shares in Tatva Chintan Pharma Chem were trading -17.23% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tatva Chintan Pharma Chem PE ratio based on its reported earnings over the past 12 months is 46.71. The shares last closed at IN₹725.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Tatva Chintan Pharma Chem's directors